Researchers have found that treatment with an immunotherapy drug is superior to standard chemotherapy for children with leukemia that has relapsed. The findings, based on a clinical trial, focused on the immunotherapy drug blinatumomab. Subjects in the trial were children and young adults with high- or intermediate-risk B-cell acute lymphoblastic leukemia (B-ALL) that has relapsed.… Continue reading Immunotherapy Better than Chemotherapy for Some Kids with Leukemia